These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 676253)

  • 1. [Concentration and excretion of isoniazid and PAS in patients with tuberculosis depending on the functional status of the kidney].
    Savula MM; Kiselova ES
    Vrach Delo; 1978 May; (5):119-22. PubMed ID: 676253
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
    Savula MM; Kiselova ES
    Probl Tuberk; 1974; (8):43-6. PubMed ID: 4409368
    [No Abstract]   [Full Text] [Related]  

  • 3. [Liver function and INH and PAS metabolism in tuberculous adolescents with side reactions to chemotherapy].
    Tytor IaN; Koropetskiĭ VI
    Vrach Delo; 1977 Jun; (6):61-4. PubMed ID: 883281
    [No Abstract]   [Full Text] [Related]  

  • 4. [Excretion and concentration of tubazid, PAS and their metabolites in patients with tuberculosis and different functional conditions of kidneys].
    Savula MM
    Sov Med; 1973 Sep; 36(9):146-7. PubMed ID: 4756491
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isoniazid and PAS metabolism and bacteriostatic activity of blood in adolescents with intrathoracic tuberculosis].
    Tytor IaM
    Probl Tuberk; 1975; (7):51-4. PubMed ID: 1082592
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peculiarities of PAS and tubazid metabolism in tuberculous patients treated with nerobol and ATP].
    Sabula MM
    Probl Tuberk; 1972; 50(1):47-50. PubMed ID: 5010779
    [No Abstract]   [Full Text] [Related]  

  • 7. [Active fraction of isonicotinic acid hydrazide in the blood of tuberculosis patients during its combined use with PAS].
    Dudchik GKh; Bilyk MA
    Vrach Delo; 1981 Feb; (2):77-8. PubMed ID: 7222619
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetics of isoniazid, PAS, and cycloserin in acute and chronic alcoholic intoxication (experimental study)].
    Ortenberg ZA
    Probl Tuberk; 1978 Sep; (9):60-4. PubMed ID: 568263
    [No Abstract]   [Full Text] [Related]  

  • 9. [Functional state of the liver and the metabolism of isoniazid and PASA in adolescents with intrathoracic tuberculosis].
    Tytor IaN
    Probl Tuberk; 1976 Jul; (7):29-32. PubMed ID: 959195
    [No Abstract]   [Full Text] [Related]  

  • 10. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acetylation phenotype and biotransformation of various drugs].
    Grygorowicz J; Januszko J
    Wiad Lek; 1987 Mar; 40(5):319-23. PubMed ID: 3303698
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of isoniazid and PAS on various biochemical indices of liver function in patients with tuberculosis].
    Savula MM; Tytor IaN
    Vrach Delo; 1983 Jul; (7):16-9. PubMed ID: 6624048
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of chemotherapy and short-term pneumoperitoneum in the treatment of destructive pulmonary tuberculosis].
    Ursov IG; Reĭkhrud VM
    Probl Tuberk; 1976 Nov; (11):27-30. PubMed ID: 1019122
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G; Petitjean R; Schranz J; Scherrer B
    Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in various parameters of homeostasis in patients with pulmonary tuberculosis after intra-arterial administration of antibacterial preparations].
    Goncharov VG; Kovalenko NN
    Probl Tuberk; 1985; (9):56-9. PubMed ID: 4070224
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled intermittent treatment of pulmonary tuberculosis using streptomycin, isoniazid and PAS once, twice or 3 times a week].
    el-Fassi el-Fahri M; Burzoni FJ; Durante C; Ceicu A
    Bull Int Union Tuberc; 1973 Dec; 48 Suppl():158-65. PubMed ID: 4611550
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum concentration and urinary excretion of ethambutol administered alone and in combination with isoniazid in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Varshney DP; Kishore K
    Indian J Physiol Pharmacol; 1985; 29(4):223-6. PubMed ID: 3842376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S; Grella G
    Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract]   [Full Text] [Related]  

  • 19. [Isoniazide-tiocarlide combination or DAT in the treatment of pulmonary tuberculosis. Comparison with isoniazide-PAS combination and especially BPAS].
    Meyer A; Nadjar-Fossé G
    Rev Tuberc Pneumol (Paris); 1968; 32(3):371-80. PubMed ID: 5693998
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of liver function in pulmonary tuberculosis with the aid of ueviridin test and the indicators of urinary excretion of antitubercular agents].
    Savula MM; Tytor IaM; Piatnochka IT
    Sov Med; 1976 Nov; (11):109-12. PubMed ID: 1006371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.